BHC:NYE-Bausch Health Companies Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 9.69

Change

+0.43 (+4.64)%

Market Cap

USD 3.56B

Volume

3.35M

Analyst Target

USD 26.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. Address: 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+0.09 (+0.05%)

USD 85.62B
RDY Dr. Reddy’s Laboratories Ltd..

-59.38 (-80.25%)

USD 63.63B
TAK Takeda Pharmaceutical Co Ltd A..

+0.17 (+1.21%)

USD 44.45B
HLN Haleon plc

+0.01 (+0.10%)

USD 43.99B
CTLT Catalent Inc

-0.21 (-0.36%)

USD 10.78B
ELAN Elanco Animal Health

+0.11 (+0.88%)

USD 6.18B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.16 (-1.90%)

USD 2.55B
CPHI China Pharma Holdings Inc

-0.01 (-3.80%)

USD 4.03M
YCBD cbdMD Inc

-0.01 (-2.17%)

USD 2.11M
EBS Emergent Biosolutions Inc

+0.19 (+2.17%)

N/A

ETFs Containing BHC

MJJ 9.90 % 0.00 %

N/A

N/A
MJO 9.90 % 0.00 %

N/A

N/A
FMK 4.35 % 0.70 %

N/A

N/A
ITA 4.11 % 0.42 %

N/A

N/A
DDOC:XETRA Global X Telemedicine & D.. 3.80 % 0.00 %

+0.06 (+0.00%)

USD 5.39M
BUZ 3.50 % 0.75 %

N/A

N/A
XCS:CA iShares S&P/TSX Small Cap 1.39 % 0.61 %

+0.02 (+0.00%)

CAD 0.15B
OEW 1.25 % 0.40 %

N/A

N/A
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.86 % 0.00 %

-0.11 (0.00%)

USD 0.18B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.84 % 0.00 %

-0.24 (0.00%)

USD 0.14B
SYBK:XETRA SPDR Barclays 0-5 Year US.. 0.84 % 0.00 %

-0.06 (0.00%)

USD 0.13B
SJNK:SW SPDR® Bloomberg SASB U.S.. 0.84 % 0.00 %

N/A

USD 0.18B
SJNK:LSE SSgA SPDR ETFs Europe I p.. 0.74 % 0.00 %

+0.03 (+0.00%)

N/A
BND Vanguard Total Bond Marke.. 0.01 % 0.04 %

+0.18 (+0.00%)

N/A
BSJL 0.00 % 0.41 %

N/A

N/A
CJNK 0.00 % 0.30 %

N/A

N/A
FIW First Trust Water ETF 0.00 % 0.55 %

+1.86 (+0.00%)

N/A
HYG iShares iBoxx $ High Yiel.. 0.00 % 0.49 %

+0.22 (+0.00%)

N/A
IYJ 0.00 % 0.42 %

N/A

N/A
RFUN 0.00 % 0.51 %

N/A

N/A
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

+0.14 (+0.00%)

USD 0.11B
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

+0.03 (+0.00%)

CAD 0.05B
HYGV FlexShares® High Yield V.. 0.00 % 0.37 %

+0.13 (+0.00%)

USD 1.48B
PHYL PGIM Active High Yield Bo.. 0.00 % 0.00 %

+0.02 (+0.00%)

USD 0.16B
SJB ProShares Short High Yiel.. 0.00 % 0.95 %

-0.05 (0.00%)

USD 0.08B
VNLA Janus Henderson Short Dur.. 0.00 % 0.35 %

+0.01 (+0.00%)

USD 2.24B
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

N/A
HYLB Xtrackers USD High Yield .. 0.00 % 0.20 %

+0.10 (+0.00%)

USD 3.49B
BSJP Invesco BulletShares 2025.. 0.00 % 0.42 %

+0.03 (+0.00%)

USD 0.99B
WNDU:LSE SPDR® MSCI World Industr.. 0.00 % 0.00 %

+0.67 (+0.00%)

N/A
XDWI:LSE Xtrackers MSCI World Indu.. 0.00 % 0.00 %

+0.47 (+0.00%)

N/A
DXS3:F Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

-0.08 (0.00%)

N/A
SYBJ:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

+0.04 (+0.00%)

USD 0.58B
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

+0.05 (+0.00%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.82% 60% D- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.82% 60% D- 78% C+
Trailing 12 Months  
Capital Gain 33.66% 67% D+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.66% 67% D+ 78% C+
Trailing 5 Years  
Capital Gain -62.75% 29% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.75% 29% F 10% F
Average Annual (5 Year Horizon)  
Capital Gain -5.82% 20% F 11% F
Dividend Return -5.82% 20% F 8% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 50.93% 33% F 18% F
Risk Adjusted Return -11.42% 27% F 16% F
Market Capitalization 3.56B 40% F 74% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector